Flynn, Terry N.; Kelsey, Stephen M.; Hazel, Dena L.; … - In: PharmacoEconomics 16 (1999) 5, pp. 543-550
Objective: To assess the economic impact of adding granulocyte colony-stimulating factor (G-CSF) to amphotericin B to … used to calculate the cost effectiveness of using amphotericin B plus G-CSF compared to amphotericin B monotherapy in … malignancy. Interventions: 29 patients received intravenous amphotericin B (1 mg/kg daily) plus subcutaneous G-CSF (3 to 5 microg …